UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5951
VOC Energy
VOC
$51.9M
| $417K | ﹤0.01% |
+87,179
| New | +$437K |
|
5952
Caesarstone
CSTE
$79.5M
| $416K | ﹤0.01% |
97,929
+86,877
| +786% | +$382K |
|
5953
Shinhan Financial Group
SHG
$35.6B
| $416K | ﹤0.01% |
12,656
+8,868
| +234% | +$343K |
|
5954
PMV Pharmaceuticals
PMVP
$63.5M
| $416K | ﹤0.01% |
275,464
+96,598
| +54% | +$153K |
|
|
PNI
5955
PIMCO New York Municipal Income Fund II
PNI
$77.7M
| $416K | ﹤0.01% |
58,079
-42,596
| -42% | -$318K |
|
5956
Northeast Community Bancorp
NECB
$367M
| $415K | ﹤0.01% |
16,984
+9,268
| +120% | +$255K |
|
5957
Rocky Mountain Chocolate Factory
RMCF
$7.84M
| $415K | ﹤0.01% |
170,911
+125,769
| +279% | +$320K |
|
5958
Lifezone Metals
LZM
$370M
| $414K | ﹤0.01% |
59,635
+42,329
| +245% | +$283K |
|
5959
Invesco S&P 500 Equal Weight Real Estate ETF
RSPR
$102M
| $414K | ﹤0.01% |
11,778
+1,941
| +20% | +$72K |
|
5960
Syntax Stratified LargeCap ETF
SSPY
$131M
| $414K | ﹤0.01% |
5,310
+4,792
| +925% | +$383K |
|
5961
Real Brokerage
REAX
$466M
| $414K | ﹤0.01% |
90,080
+16,842
| +23% | +$88.3K |
|
5962
Savara
SVRA
$1.19B
| $414K | ﹤0.01% |
134,924
-35,155
| -21% | -$123K |
|
|
OPPE
5963
WisdomTree European Opportunities Fund
OPPE
$295M
| $414K | ﹤0.01% |
10,835
-2,366
| -18% | -$90.6K |
|
5964
ProShares Ultra Semiconductors
USD
$2.95B
| $414K | ﹤0.01% |
+12,704
| New | +$422K |
|
|
BOW
5965
Bowhead Specialty Holdings
BOW
$1.1B
| $414K | ﹤0.01% |
11,645
+6,838
| +142% | +$224K |
|
|
CLLS
5966
Cellectis
CLLS
$285M
| $412K | ﹤0.01% |
+229,081
| New | +$427K |
|
5967
Monte Rosa Therapeutics
GLUE
$1.35B
| $412K | ﹤0.01% |
59,399
+34,066
| +134% | +$256K |
|
5968
Design Therapeutics
DSGN
$876M
| $411K | ﹤0.01% |
66,587
+51,707
| +347% | +$299K |
|
5969
Nuveen Virginia Quality Municipal Income Fund
NPV
$214M
| $410K | ﹤0.01% |
32,442
-36,470
| -53% | -$478K |
|
5970
Hallador Energy
HNRG
$696M
| $410K | ﹤0.01% |
35,837
+23,839
| +199% | +$266K |
|
5971
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $409K | ﹤0.01% |
5,962
-5,647
| -49% | -$384K |
|
5972
Vuzix
VUZI
$224M
| $409K | ﹤0.01% |
103,862
+103,450
| +25,109% | +$212K |
|
|
PNNT
5973
Pennant Park Investment Corp
PNNT
$241M
| $408K | ﹤0.01% |
57,615
+32,540
| +130% | +$226K |
|
|
FLC
5974
Flaherty & Crumrine Total Return Fund
FLC
$175M
| $407K | ﹤0.01% |
24,388
-14,598
| -37% | -$247K |
|
5975
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$141M
| $406K | ﹤0.01% |
8,197
+889
| +12% | +$46.3K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.